FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024574150> ?p ?o ?g. }

• W2024574150 endingPage "217" @default.
• W2024574150 startingPage "209" @default.
• W2024574150 abstract "Network meta-analysis techniques (meta-analysis, adjusted indirect comparison, and mixed treatment comparison [MTC]) allow for treatment comparisons in the absence of head-to-head trials. In this study, conditional estimates of relative treatment efficacy derived through these techniques show important differences in the fracture risk reduction profiles of marketed pharmacologic therapies for postmenopausal osteoporosis.This study illustrates how network meta-analysis techniques (meta-analysis, adjusted indirect comparison, and MTC) can provide comparisons of the relative efficacy of postmenopausal osteoporosis therapies in the absence of comprehensive head-to-head trials.Source articles were identified in MEDLINE; EMBASE; Cochrane Central Register of Controlled Trials (CENTRAL) via Wiley Interscience; and Cumulative Index to Nursing and Allied Health Literature (CINAHL) between April 28, 2009 and November 4, 2009. Two reviewers identified English-language articles reporting randomized controlled trials (RCTs) with on-label dosing of marketed osteoporosis agents and fracture endpoints. Trial design, population characteristics, intervention and comparator, fracture outcomes, and adverse events were abstracted for analysis. Primary analyses included data from RCTs with fracture endpoints. Sensitivity analyses also included studies with fractures reported through adverse event reports. Meta-analysis compared fracture outcomes for pharmacological therapies vs. placebo (fixed and random effects models); adjusted indirect comparisons and MTC assessed fracture risk in postmenopausal women treated with denosumab vs. other agents.Using data from 34 studies, random effects meta-analysis showed that all agents except etidronate significantly reduced the risk of new vertebral fractures compared with placebo; denosumab, risedronate, and zoledronic acid significantly reduced the risk for nonvertebral and hip fracture, while alendronate, strontium ranelate, and teriparatide significantly reduced the risk for nonvertebral fractures. MTC showed denosumab to be more effective than strontium ranelate, raloxifene, alendronate, and risedronate in preventing new vertebral fractures.The conditional estimates of relative treatment efficacy indicate that there are important differences in fracture risk reduction profiles for marketed pharmacological therapies for postmenopausal osteoporosis." @default.
• W2024574150 created "2016-06-24" @default.
• W2024574150 creator A5014718244 @default.
• W2024574150 creator A5026952227 @default.
• W2024574150 creator A5031103837 @default.
• W2024574150 creator A5044534049 @default.
• W2024574150 creator A5048640756 @default.
• W2024574150 creator A5052312125 @default.
• W2024574150 creator A5076406808 @default.
• W2024574150 date "2012-07-26" @default.
• W2024574150 modified "2023-10-04" @default.
• W2024574150 title "Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis" @default.
• W2024574150 cites W18924068 @default.
• W2024574150 cites W1968929544 @default.
• W2024574150 cites W1978097115 @default.
• W2024574150 cites W1986215651 @default.
• W2024574150 cites W1992447918 @default.
• W2024574150 cites W2005947177 @default.
• W2024574150 cites W2015489649 @default.
• W2024574150 cites W2038586192 @default.
• W2024574150 cites W2056271161 @default.
• W2024574150 cites W2068149973 @default.
• W2024574150 cites W2083411636 @default.
• W2024574150 cites W2092186339 @default.
• W2024574150 cites W2107328434 @default.
• W2024574150 cites W2113144077 @default.
• W2024574150 cites W2123346255 @default.
• W2024574150 cites W2125776201 @default.
• W2024574150 cites W2147751610 @default.
• W2024574150 cites W2328900081 @default.
• W2024574150 cites W24088030 @default.
• W2024574150 doi "https://doi.org/10.1007/s00198-012-2068-9" @default.
• W2024574150 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3662000" @default.
• W2024574150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22832638" @default.
• W2024574150 hasPublicationYear "2012" @default.
• W2024574150 type Work @default.
• W2024574150 sameAs 2024574150 @default.
• W2024574150 citedByCount "121" @default.
• W2024574150 countsByYear W20245741502013 @default.
• W2024574150 countsByYear W20245741502014 @default.
• W2024574150 countsByYear W20245741502015 @default.
• W2024574150 countsByYear W20245741502016 @default.
• W2024574150 countsByYear W20245741502017 @default.
• W2024574150 countsByYear W20245741502018 @default.
• W2024574150 countsByYear W20245741502019 @default.
• W2024574150 countsByYear W20245741502020 @default.
• W2024574150 countsByYear W20245741502021 @default.
• W2024574150 countsByYear W20245741502022 @default.
• W2024574150 countsByYear W20245741502023 @default.
• W2024574150 crossrefType "journal-article" @default.
• W2024574150 hasAuthorship W2024574150A5014718244 @default.
• W2024574150 hasAuthorship W2024574150A5026952227 @default.
• W2024574150 hasAuthorship W2024574150A5031103837 @default.
• W2024574150 hasAuthorship W2024574150A5044534049 @default.
• W2024574150 hasAuthorship W2024574150A5048640756 @default.
• W2024574150 hasAuthorship W2024574150A5052312125 @default.
• W2024574150 hasAuthorship W2024574150A5076406808 @default.
• W2024574150 hasBestOaLocation W20245741502 @default.
• W2024574150 hasConcept C126322002 @default.
• W2024574150 hasConcept C142724271 @default.
• W2024574150 hasConcept C168563851 @default.
• W2024574150 hasConcept C1862650 @default.
• W2024574150 hasConcept C197934379 @default.
• W2024574150 hasConcept C204787440 @default.
• W2024574150 hasConcept C27081682 @default.
• W2024574150 hasConcept C2776286101 @default.
• W2024574150 hasConcept C2776326535 @default.
• W2024574150 hasConcept C2776541429 @default.
• W2024574150 hasConcept C2778885795 @default.
• W2024574150 hasConcept C44249647 @default.
• W2024574150 hasConcept C71924100 @default.
• W2024574150 hasConcept C82789193 @default.
• W2024574150 hasConcept C95190672 @default.
• W2024574150 hasConceptScore W2024574150C126322002 @default.
• W2024574150 hasConceptScore W2024574150C142724271 @default.
• W2024574150 hasConceptScore W2024574150C168563851 @default.
• W2024574150 hasConceptScore W2024574150C1862650 @default.
• W2024574150 hasConceptScore W2024574150C197934379 @default.
• W2024574150 hasConceptScore W2024574150C204787440 @default.
• W2024574150 hasConceptScore W2024574150C27081682 @default.
• W2024574150 hasConceptScore W2024574150C2776286101 @default.
• W2024574150 hasConceptScore W2024574150C2776326535 @default.
• W2024574150 hasConceptScore W2024574150C2776541429 @default.
• W2024574150 hasConceptScore W2024574150C2778885795 @default.
• W2024574150 hasConceptScore W2024574150C44249647 @default.
• W2024574150 hasConceptScore W2024574150C71924100 @default.
• W2024574150 hasConceptScore W2024574150C82789193 @default.
• W2024574150 hasConceptScore W2024574150C95190672 @default.
• W2024574150 hasIssue "1" @default.
• W2024574150 hasLocation W20245741501 @default.
• W2024574150 hasLocation W20245741502 @default.
• W2024574150 hasLocation W20245741503 @default.
• W2024574150 hasLocation W20245741504 @default.
• W2024574150 hasOpenAccess W2024574150 @default.
• W2024574150 hasPrimaryLocation W20245741501 @default.
• W2024574150 hasRelatedWork W1988483679 @default.
• W2024574150 hasRelatedWork W2032912145 @default.
• W2024574150 hasRelatedWork W2052478621 @default.

• next